4//SEC Filing
Sauer Paul 4
Accession 0001209191-21-025999
CIK 0001649094other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 9:17 PM ET
Size
15.1 KB
Accession
0001209191-21-025999
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
- Other
Common Stock
2021-04-05−38,308→ 39,591 total - Other
Stock Option (right to buy)
2021-04-05−4,168→ 4,168 totalExercise: $0.80Exp: 2026-04-19→ Common Stock (4,168 underlying) - Other
Stock Option (right to buy)
2021-04-05−14,253→ 7,173 totalExercise: $1.79Exp: 2027-05-17→ Common Stock (14,253 underlying) - Other
Stock Option (right to buy)
2021-04-05−7,611→ 22,027 totalExercise: $2.03Exp: 2029-03-20→ Common Stock (7,611 underlying) - Other
Stock Option (right to buy)
2021-04-05−21,871→ 48,197 totalExercise: $2.03Exp: 2028-07-23→ Common Stock (21,871 underlying)
Footnotes (4)
- [F1]Transfer of shares and the reporting person's economic interest in stock options (right to buy) to reporting person's spouse pursuant to a property settlement agreement in connection with separation proceedings. While the reporting person will retain the options, the reporting person's spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Accordingly, the reporting person will not report beneficial ownership of or dispositions of the portion of such options representing the spouse's transferred economic interest, nor will the reporting person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.
- [F2]The shares subject to the option representing the reporting person's remaining economic interest are fully vested and exercisable.
- [F3]As of the date of transfer, the shares subject to the option representing the reporting person's remaining economic interest will vest in monthly installments with respect to 1,459 shares from April 24, 2021 to July 24, 2022.
- [F4]As of the date of transfer, the shares subject to the option representing the reporting person's remaining economic interest will vest in monthly installments with respect to 617 shares from May 1, 2021 to January 1, 2023.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001813796
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 9:17 PM ET
- Size
- 15.1 KB